Cytheris' Series D Round

Cytheris raised a round of funding on June 24, 2010.

Cytheris is dedicated to the development of growth factors able to enhance, drive and restore immune system functions. The company is particularly interested in a recombinant human interleukin-7 for i…

Articles about Cytheris' Series D Round: